Lifetime prevalence of psychiatric disorders in patients with alopecia areata
- PMID: 1884604
- DOI: 10.1016/0010-440x(91)90045-e
Lifetime prevalence of psychiatric disorders in patients with alopecia areata
Abstract
Thirty-one patients with alopecia areata were administered a structured psychiatric interview (the Diagnostic Interview Schedule; DIS). Overall, 74% had one or more lifetime psychiatric diagnoses. Particularly noteworthy were the high lifetime prevalence rates of major depression (39%) and generalized anxiety disorder (39%). In addition, patients reported increased rates of psychiatric disorders in first-degree relatives: anxiety disorders (58%), affective disorders (35%), and substance use disorders (35%). Patients with patchy alopecia areata were more likely to have a diagnosis of generalized anxiety disorder. No relationships were found between major depression and any variable characterizing alopecia areata history. Possible interrelationships between psychiatric disorders and alopecia areata are discussed. The study suggests that patients with alopecia areata are at increased risk for psychiatric disorders, and calls attention to the need for psychiatric assessment in this population.
Similar articles
-
Comorbidity of psychiatric disorders in children and adolescents with alopecia areata in a child and adolescent psychiatry clinical sample.Int J Dermatol. 2008 Nov;47(11):1118-20. doi: 10.1111/j.1365-4632.2008.03743.x. Int J Dermatol. 2008. PMID: 18986440
-
Alopecia areata and increased prevalence of psychiatric disorders.Int J Dermatol. 1994 Dec;33(12):849-50. doi: 10.1111/j.1365-4362.1994.tb01018.x. Int J Dermatol. 1994. PMID: 7883407
-
Psychological and psychopathological factors in alopecia areata.Psychiatr Pol. 2015;49(5):955-64. doi: 10.12740/PP/39064. Psychiatr Pol. 2015. PMID: 26688846 Review. English, Polish.
-
Psychosomatic aspects of alopecia areata.Clin Dermatol. 2018 Nov-Dec;36(6):709-713. doi: 10.1016/j.clindermatol.2018.08.011. Epub 2018 Aug 16. Clin Dermatol. 2018. PMID: 30446192
-
Alopecia areata, stress and psychiatric disorders: a review.J Dermatol. 1999 Oct;26(10):625-32. doi: 10.1111/j.1346-8138.1999.tb02063.x. J Dermatol. 1999. PMID: 10554427 Review.
Cited by
-
Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model.AAPS J. 2024 Jan 24;26(1):17. doi: 10.1208/s12248-024-00888-9. AAPS J. 2024. PMID: 38267790
-
The impact, prevalence, and association of different forms of hair loss among individuals with anxiety disorder: Systematic review and meta-analysis.Medicine (Baltimore). 2025 Feb 7;104(6):e41457. doi: 10.1097/MD.0000000000041457. Medicine (Baltimore). 2025. PMID: 39928820 Free PMC article.
-
Immunopathogenesis of alopecia areata.Curr Res Immunol. 2021 Feb 6;2:7-11. doi: 10.1016/j.crimmu.2021.02.001. eCollection 2021. Curr Res Immunol. 2021. PMID: 35492401 Free PMC article. Review.
-
Severity of Depression and Anxiety in Patients with Alopecia Areata in Bandar Abbas, Iran.Dermatol Reports. 2015 Dec 22;7(3):6063. doi: 10.4081/dr.2015.6063. eCollection 2015 Dec 3. Dermatol Reports. 2015. PMID: 26734119 Free PMC article.
-
Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP).JAAD Case Rep. 2015 Aug 25;1(5):305-7. doi: 10.1016/j.jdcr.2015.07.004. eCollection 2015 Sep. JAAD Case Rep. 2015. PMID: 27051761 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical